Literature DB >> 20722968

The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

David M Thomas1, Mariana Angoa Pérez, Dina M Francescutti-Verbeem, Mrudang M Shah, Donald M Kuhn.   

Abstract

Methamphetamine (METH) is a neurotoxic drug of abuse that damages the dopamine (DA) neuronal system in a highly delimited manner. The brain structure most affected by METH is the striatum where long-term DA depletion and microglial activation are maximal. Endogenous DA has been implicated as a critical participant in METH-induced neurotoxicity, most likely as a substrate for non-enzymatic oxidation by METH-generated reactive oxygen species. The striatum is also extensively innervated by serotonin (5HT) nerve endings and this neurochemical system is modified by METH in much the same manner as seen in DA nerve endings (i.e., increased release of 5HT, loss of function in tryptophan hydroxylase and the serotonin transporter, long-term depletion of 5HT stores). 5HT can also be modified by reactive oxygen species to form highly reactive species that damage neurons but its role in METH neurotoxicity has not been assessed. Increases in 5HT levels with 5-hydroxytryptophan do not change METH-induced neurotoxicity to the DA nerve endings as revealed by reductions in DA, tyrosine hydroxylase and dopamine transporter levels. Partial reductions in 5HT with p-chlorophenylalanine are without effect on METH toxicity, despite the fact that p-chlorophenylalanine largely prevents METH-induced hyperthermia. Mice lacking the gene for brain tryptophan hydroxylase 2 are devoid of brain 5HT and respond to METH in the same manner as wild-type controls, despite showing enhanced drug-induced hyperthermia. Taken together, the present results indicate that endogenous 5HT does not appear to play a role in METH-induced damage to DA nerve endings of the striatum.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20722968      PMCID: PMC2974310          DOI: 10.1111/j.1471-4159.2010.06950.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  77 in total

1.  Tyrosine hydroxylase: purification from PC-12 cells, characterization and production of antibodies.

Authors:  D M Kuhn; M L Billingsley
Journal:  Neurochem Int       Date:  1987       Impact factor: 3.921

Review 2.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity.

Authors:  J Yuan; B T Callahan; U D McCann; G A Ricaurte
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

Review 4.  Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.

Authors:  M Z Wrona; Z Yang; F Zhang; G Dryhurst
Journal:  NIDA Res Monogr       Date:  1997

5.  Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders.

Authors:  M Z Wrona; G Dryhurst
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

6.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

7.  Phosphorylation and activation of tryptophan hydroxylase 2: identification of serine-19 as the substrate site for calcium, calmodulin-dependent protein kinase II.

Authors:  Donald M Kuhn; Stacey A Sakowski; Timothy J Geddes; Curtis Wilkerson; John W Haycock
Journal:  J Neurochem       Date:  2007-08-28       Impact factor: 5.372

8.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

9.  Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.

Authors:  M Johnson; P K Sonsalla; A A Letter; G R Hanson; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

10.  Growth retardation and altered autonomic control in mice lacking brain serotonin.

Authors:  Natalia Alenina; Dana Kikic; Mihail Todiras; Valentina Mosienko; Fatimunnisa Qadri; Ralph Plehm; Philipp Boyé; Larissa Vilianovitch; Reinhard Sohr; Katja Tenner; Heide Hörtnagl; Michael Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

View more
  27 in total

1.  The sleep-wake cycle and motor activity, but not temperature, are disrupted over the light-dark cycle in mice genetically depleted of serotonin.

Authors:  Julia Z Solarewicz; Mariana Angoa-Perez; Donald M Kuhn; Jason H Mateika
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

2.  Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Authors:  Gabriel C Loewinger; Michael V Beckert; Hugo A Tejeda; Joseph F Cheer
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

3.  Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Catherine E Sykes; Mrudang M Shah; Dina M Francescutti; David R Rosenberg; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-04-13       Impact factor: 5.372

4.  Ventilatory long-term facilitation is evident after initial and repeated exposure to intermittent hypoxia in mice genetically depleted of brain serotonin.

Authors:  Stephen Hickner; Najaah Hussain; Mariana Angoa-Perez; Dina M Francescutti; Donald M Kuhn; Jason H Mateika
Journal:  J Appl Physiol (1985)       Date:  2013-12-12

Review 5.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

Review 6.  A review of treatment options for co-occurring methamphetamine use disorders and depression.

Authors:  Tracy L Hellem; Kelly J Lundberg; Perry F Renshaw
Journal:  J Addict Nurs       Date:  2015 Jan-Mar       Impact factor: 1.476

7.  Investigation of the protective effect of Paeonia lactiflora on Semen Strychni-induced neurotoxicity based on monitoring nine potential neurotoxicity biomarkers in rat serum and brain tissue.

Authors:  Huiyan Shi; Chenzhi Hou; Liqiang Gu; Hang Xing; Meiyu Zhang; Longshan Zhao; Kaishun Bi; Xiaohui Chen
Journal:  Metab Brain Dis       Date:  2016-08-13       Impact factor: 3.584

8.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Catherine E Sykes; Mrudang M Shah; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2013-01-08       Impact factor: 5.372

9.  Involvement of the α(1D)-adrenergic receptor in methamphetamine-induced hyperthermia and neurotoxicity in rats.

Authors:  Kazue Kikuchi-Utsumi; Mami Ishizaka; Nobuko Matsumura; Masahiko Watabe; Koji Aoyama; Nobuyuki Sasakawa; Toshio Nakaki
Journal:  Neurotox Res       Date:  2013-01-03       Impact factor: 3.911

10.  Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Donald M Kuhn
Journal:  J Vis Exp       Date:  2013-12-24       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.